Abstract
The effect of buprenorphine on bremazocine-induced diuresis was tested in the rat to determine the nature of buprenorphine's action at the ϰ opioid receptor. Both morphine-tolerant and naive rats were used to account for possible antidiuretic effects of buprenorphine at the µ site. Separate experiments established that the morphine pretreatment caused profound tolerance with respect to the antidiuretic action of µ agonists. Buprenorphine acted as a potent antagonist (ID50 = 11µg/kg) of the diuretic action of the ϰ agonist bremazocine (ED50 = l0 µg/kg). The similar potency of buprenorphine as an antagonist of bremazocine in naive and morphine-tolerant rats further supports the hypothesis that buprenorphine exerts it's antidiuresis via an antagonistic effect at ϰ sites, rather than as an agonist at the µ sites. The high affinity displayed by buprenorphine at the ϰ opioid receptor in vivo is consistent with this conclusion. Hence, buprenorphine can now be classified as a partial agonist at the µ site and as an antagonist at the ϰ site against bremazocine induced urine flow, while its action at the δ site to which it has much lower affinity in vivo remains unknown.
Similar content being viewed by others
References
Dum, J. E., Herz, A. (1981) Brit. J. Pharmacol. 74, 627–633.
Rance, M. J., Lord, J. A. H., Robinson, T. (1980) in Endogenous and Exogenous Opiate Agonists and Antagonists (Way, E. L., ed.), pp. 387–390, Pergamon Press.
Sadée, W., Richards, M. L., Grevel, J., Rosenbaum, J. S. (1983) Life Sci. 33 (Sup. I), 187–189.
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., Gilbert, P. E. (1976) J. Pharmacol. Exp. Ther. 197, 517–532.
Tyers, M. B. (1980) Brit. J. Pharmacol. 69, 503–512.
Skingle, M., Tyers, M. B. (1980) Brit. J. Pharmacol. 70, 323–327.
Richards, M. L., Sadée, W. (1985) J. Pharmacol. Exp. Ther. (in press).
Leander, J. D. (1983) J. Pharmacol. Exp. Ther. 224, 89–94.
Huidobro, F. (1978) Brit. J. Pharmacol. 64, 167–171.
Huidobro, F., Huidobro-Toro, J. P. (1979) Eur. J. Pharmacol. 59, 55–64.
Dray, A., Metsch, R. (1984) Eur. J. Pharmacol. 104, 47–53.
Dray, A., Metsch, R. (1984) J. Pharmacol. Exp. Ther. 231, 254–260.
Dum, J., Blasig, J., Herz, A. (1981) Eur. J. Pharmacol. 70, 293–300.
Rosenbaum, J. S., Holford, N. H. G., Sadée, W. (1984) Brain Res. 291, 317–324.
Maurer, R. (1984) J. Recept. Res. (in press).
Shearman, G. T., Herz, A. (1982) Psychopharmacol. 78, 63–66.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Richards, M.L., Sadée, W. Buprenorphine is an Antagonist at the ϰ Opioid Receptor. Pharm Res 2, 178–181 (1985). https://doi.org/10.1023/A:1016340106299
Issue Date:
DOI: https://doi.org/10.1023/A:1016340106299